Triple
T7392987
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | George Church |
E170546
|
entity |
| Predicate | coFounded |
P104
|
FINISHED |
| Object |
Colossal Biosciences
Colossal Biosciences is a biotechnology company focused on de-extinction and advanced genetic engineering, best known for its efforts to revive extinct species such as the woolly mammoth.
|
E661991
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Colossal Biosciences | Statement: [George Church, coFounded, Colossal Biosciences]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Colossal Biosciences Context triple: [George Church, coFounded, Colossal Biosciences]
-
A.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
B.
Verily Life Sciences LLC
Verily Life Sciences LLC is a health-focused research and technology company that develops tools and platforms to collect, organize, and analyze health data, particularly in areas like clinical research, precision health, and disease management.
-
C.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
D.
Ridgeback Biotherapeutics
Ridgeback Biotherapeutics is a biotechnology company focused on developing antiviral and immunotherapy treatments for serious infectious diseases, including Ebola and COVID-19.
-
E.
Aurora Innovation
Aurora Innovation is an autonomous vehicle technology company focused on developing self-driving systems for cars, trucks, and other vehicles.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Colossal Biosciences Triple: [George Church, coFounded, Colossal Biosciences]
Generated description
Colossal Biosciences is a biotechnology company focused on de-extinction and advanced genetic engineering, best known for its efforts to revive extinct species such as the woolly mammoth.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Colossal Biosciences Target entity description: Colossal Biosciences is a biotechnology company focused on de-extinction and advanced genetic engineering, best known for its efforts to revive extinct species such as the woolly mammoth.
-
A.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
B.
Verily Life Sciences LLC
Verily Life Sciences LLC is a health-focused research and technology company that develops tools and platforms to collect, organize, and analyze health data, particularly in areas like clinical research, precision health, and disease management.
-
C.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
D.
Ridgeback Biotherapeutics
Ridgeback Biotherapeutics is a biotechnology company focused on developing antiviral and immunotherapy treatments for serious infectious diseases, including Ebola and COVID-19.
-
E.
Aurora Innovation
Aurora Innovation is an autonomous vehicle technology company focused on developing self-driving systems for cars, trucks, and other vehicles.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c68a5e2c9081909e713ce866e0060a |
completed | March 27, 2026, 1:47 p.m. |
| NER | Named-entity recognition | batch_69c6f224790c819099ceb7c7ac8d00f6 |
completed | March 27, 2026, 9:09 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c810f82ba08190919924b0994a2eee |
completed | March 28, 2026, 5:33 p.m. |
| NEDg | Description generation | batch_69c811f1fe3c8190a591186b19044b5f |
completed | March 28, 2026, 5:37 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69c812c1e9d08190b0e7f052d87011b9 |
completed | March 28, 2026, 5:41 p.m. |
Created at: March 27, 2026, 3:09 p.m.